CompugenvsMerck & Company

CGEN and MRK stock compared: price, dividend, valuation and results, from SEC filings.

CGEN

Compugen Ltd.

$2.04

Value $192M

-0.25%
CGEN's page

MRK

Merck & Company, Inc.

$143.99

Value $356B

-0.33%
MRK's page

Compugen (CGEN) has a market value of $192M and Merck & Company (MRK) $356B. Over the last year, with dividends, CGEN moved +24.4% and MRK +59.5%. The P/E is 5.4 for CGEN and 145.1 for MRK. Dividend yield: CGEN none, MRK 2.36%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CGEN$192M

    MRK$356B

    MRK is 1,850 times CGEN

  • Revenue, 12 months

    CGEN$73M

    MRK$67.4B

    MRK is 926 times CGEN

  • Net income, 12 months

    CGEN$35M

    MRK$2.5B

    MRK is 69 times CGEN

  • Operating margin

    CGEN43.1%

    MRK–

  • ROIC

    CGEN24.1%

    MRK3.9%

    20.2 points apart

  • P/E

    CGEN5.4

    MRK145.1

    MRK is 27 times CGEN

  • Dividend yield

    CGEN0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    CGEN-60.5%

    MRK+99.4%

    159.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CGEN-60.5%

MRK+99.4%

010020020222023202420252026
Returns by period
PeriodCGENWith dividendsMRKWith dividends
1 year since November 14, 2025+24.4%Price +24.4%+59.5%Price +55.0%
3 years since November 17, 2023+234.4%+49.5% a yearPrice +234.4%+55.1%+15.8% a yearPrice +41.5%
5 years since November 16, 2021-60.5%-16.9% a yearPrice -60.5%+99.4%+14.8% a yearPrice +71.2%
10 years since November 17, 2016-68.4%-10.9% a yearPrice -68.4%+226.5%+12.6% a yearPrice +140.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CGENCompugenMRKMerck & Company

Valuation

CGENMRK
Valuation
Price$2.04$143.99
Market value$192M$356B
Enterprise value (EV)$93M$400B
P/E5.4145.1
P/E, 5-year median–14.8
P/B1.97.9
EV/EBIT3.084.0
Free cash flow yield16.3%4.1%

Results and growth

CGENMRK
Results and growth
Revenue, 12 months$73M$67.4B
Net income, 12 months$35M$2.5B
Free cash flow, 12 months$31M$14.7B
Earnings per share, 12 months$0.38$0.98
Revenue growth, year on year161.1%1.3%
Revenue growth a year, past+105.2%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

CGENMRK
Margins and returns on capital
Gross margin87.3%71.8%
Operating margin43.1%–
Net margin48.6%3.6%
ROIC24.1%3.9%
ROE34.4%5.2%

Balance sheet

CGENMRK
Balance sheet
Cash$100M$9.7B
Total debt$3.0M$53.8B
Net debt / EBITDA-3.15.7
Interest cover1,118.8×2.4×

Dividends and buybacks

CGENMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CGEN or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Compugen or Merck & Company?

By market value, Merck & Company ($356B) is about 1,850.2 times Compugen ($192M), at today's prices.

How did CGEN and MRK stock do over the last 10 years?

Since November 17, 2016, CGEN's price moved -68.4% and MRK's +140.7%. With dividends: CGEN -68.4% (-10.9% a year), MRK +226.5% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, CGEN or MRK?

The dividend yield at today's price is none for Compugen and 2.36% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of CGEN and MRK?

At today's price, the P/E is 5.4 for CGEN and 145.1 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Compugen or Merck & Company?

Over the last twelve months, the net margin was 48.6% for Compugen and 3.6% for Merck & Company, and the operating margin 43.1% and –. Revenue was $73M and $67.4B.

Which is the better investment, Compugen or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.